A recent study conducted by an international team of researchers from Imperial College London and Duke-NUS Medical School in Singapore, in collaboration with the MRC Lab of Medical Sciences, has led to promising results in the field of anti-aging.
The experiments, published in the journal Naturehave shown that an experimental drug effective in reducing the protein interleukin-11, typical of the aging phase, has significantly improved the health of mice laboratory.
Thanks to these mice, will we all be younger and more beautiful?
Interleukin-11, a protein that in early life contributes to bone formation, becomes a cause of inflammation in later years, promoting various age-related diseases.
Research has shown that, through the use of a drug capable of eliminating this protein, The mice not only showed a more youthful appearanceand a significant reduction in cancer compared to their peers, but they also had an average lifespan that was 22.4% longer in males and 25% longer in females.
The results obtained on rodents have aroused great interest in the scientific community and now the goal is to see if the treatment can have similar effects in humans. The drug, which uses an artificially produced antibody to target interleukin-11, is also being tested in humans for pulmonary fibrosis, a condition that makes breathing difficult because of scarring of the lungs.
Despite the human trials have not yet been concludedthe scientists involved are optimistic about the potential of the treatment. Professor Anissa Widjaja of Duke-NUS shared the general enthusiasm, highlighting the possibility of prolonging healthy ageing in humans with this therapy.
His colleague, Prof Stuart Cook, described the findings as “tantalising” and expressed hope that the drug may show transformative effects even in humans.
In a field often criticized for ineffective solutions, Prof. Cook made cautious but positive statements about the consistency of the data obtained. “There are many useless products on the market,” he said, “so I tend to focus on the data, which in this case is among the most compelling available.”
The possible success of this research could therefore open new frontiers in the field of anti-aging therapies.
Source: www.tomshw.it
